Bicycle Therapeutics Statistics

Total Valuation

BCYC has a market cap or net worth of $1.41 billion. The enterprise value is $526.00 million.

Market Cap	1.41B
Enterprise Value	526.00M

Important Dates

The last earnings date was Thursday, October 31, 2024, before market open.

Earnings Date	Oct 31, 2024
Ex-Dividend Date	n/a

Share Statistics

BCYC has 69.05 million shares outstanding. The number of shares has increased by 59.12% in one year.

Current Share Class	n/a
Shares Outstanding	69.05M
Shares Change (YoY)	+59.12%
Shares Change (QoQ)	+32.69%
Owned by Insiders (%)	0.85%
Owned by Institutions (%)	45.34%
Float	n/a

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	28.44
Forward PS	46.61
PB Ratio	1.69
P/TBV Ratio	1.69
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	14.26
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 17.13, with a Debt / Equity ratio of 0.01.

Current Ratio	17.13
Quick Ratio	16.82
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-78.64

Financial Efficiency

Return on equity (ROE) is -26.67% and return on invested capital (ROIC) is -18.83%.

Return on Equity (ROE)	-26.67%
Return on Assets (ROA)	-15.01%
Return on Capital (ROIC)	-18.83%
Revenue Per Employee	$129,923
Profits Per Employee	-$585,479
Employee Count	284
Asset Turnover	0.05
Inventory Turnover	n/a

Taxes

Income Tax	-3.36M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +47.00% in the last 52 weeks. The beta is 0.89, so BCYC's price volatility has been lower than the market average.

Beta (5Y)	0.89
52-Week Price Change	+47.00%
50-Day Moving Average	24.23
200-Day Moving Average	23.21
Relative Strength Index (RSI)	28.37
Average Volume (20 Days)	416,219

Short Selling Information

Short Interest	3.27M
Short Previous Month	2.92M
Short % of Shares Out	7.41%
Short % of Float	n/a
Short Ratio (days to cover)	6.85

Income Statement

In the last 12 months, BCYC had revenue of $36.90 million and -$166.28 million in losses. Loss per share was -$3.23.

Revenue	36.90M
Gross Profit	-131.15M
Operating Income	-196.44M
Pretax Income	-163.02M
Net Income	-166.28M
EBITDA	-189.32M
EBIT	-196.44M
Loss Per Share	-$3.23

Full Income Statement

Balance Sheet

The company has $890.86 million in cash and $11.09 million in debt, giving a net cash position of $879.78 million or $12.74 per share.

Cash & Cash Equivalents	890.86M
Total Debt	11.09M
Net Cash	879.78M
Net Cash Per Share	$12.74
Equity (Book Value)	831.03M
Book Value Per Share	12.04
Working Capital	909.79M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$202.62 million and capital expenditures -$918,000, giving a free cash flow of -$203.53 million.

Operating Cash Flow	-202.62M
Capital Expenditures	-918,000
Free Cash Flow	-203.53M
FCF Per Share	-$2.95

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-532.40%
Pretax Margin	-459.75%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	-416.42%

Dividends & Yields

BCYC does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-59.12%
Shareholder Yield	-59.12%
Earnings Yield	-11.83%
FCF Yield	-14.48%

Analyst Forecast

The average price target for BCYC is $40.13, which is 97.10% higher than the current price. The consensus rating is "Buy".

Price Target	$40.13
Price Target Difference	97.10%
Analyst Consensus	Buy
Analyst Count	9
Revenue Growth Forecast (5Y)	65.25%
EPS Growth Forecast (5Y)	-25.67%

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BCYC has an Altman Z-Score of 3.55 and a Piotroski F-Score of 2.

Altman Z-Score	3.55
Piotroski F-Score	2